Relates to allowing prescriptions for controlled substances that are normally restricted to a thirty-day supply to be issued for greater than a thirty-day supply during a state of emergency.
Summary
Bill A01317 amends the public health law to allow practitioners to issue prescriptions for controlled substances that typically have a thirty-day supply limit for a longer duration during emergencies. Specifically, it permits prescriptions for up to three months or even six months for certain substances if they are prescribed for conditions recognized by the commissioner. The bill aims to ensure that patients can maintain access to necessary medications during emergencies that disrupt regular pharmacy operations.
Impact
If enacted, this bill would modify existing regulations on the prescribing of controlled substances in New York, allowing for greater flexibility in prescription durations during emergencies. This change could significantly affect patients with chronic conditions who rely on these medications, ensuring they have adequate supplies during crises. It may also impact pharmacy operations and the monitoring of controlled substances, as longer prescriptions could lead to increased quantities of medications dispensed at once.
Sentiment
The sentiment surrounding Bill A01317 appears to be generally supportive, as it addresses a critical need for patients during emergencies. However, there may be concerns regarding the potential for misuse of controlled substances due to the extended prescription durations, which could lead to discussions about the balance between patient access and safety.
Contention
Notable points of contention may arise from healthcare professionals and lawmakers concerned about the potential for abuse of controlled substances if prescriptions are issued for longer periods. Some may argue that while the intent is to help patients during emergencies, it could inadvertently lead to increased risks of dependency or misuse. The bill's sponsors and supporters emphasize the necessity of ensuring patient access to medications during crises, while opponents may focus on the implications for public health and safety.
Relates to allowing prescriptions for controlled substances that are normally restricted to a thirty-day supply to be issued for greater than a thirty-day supply during a state of emergency.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.
Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.
Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.
Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.
Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.
Directs the commissioner of health to promulgate a list of prescription drugs for which an emergency thirty-day supply cannot be obtained during a state emergency.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.